Cesium carbonate → HCID 68261474, compound
Reaction equation
Br[C:2]1[CH:7]=[CH:6][C:5]([N:8]2[C:12]([CH2:13][C@@H:14]3[CH2:18][CH2:17][N:16]([C:19]([CH:21]4[CH2:23][CH2:22]4)=[O:20])[CH2:15]3)=[N:11][NH:10][C:9]2=[O:24])=[C:4]([OH:25])[CH:3]=1.CC1(C)C(C)(C)OB([C:34]2[CH:35]=[CH:36][C:37]3[O:41][CH:40]=[CH:39][C:38]=3[CH:42]=2)O1.C(=O)([O-])[O-].[Cs+].[Cs+]>C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].ClCCl>[O:41]1[C:37]2[CH:36]=[CH:35][C:34]([C:2]3[CH:7]=[CH:6][C:5]([N:8]4[C:12]([CH2:13][C@@H:14]5[CH2:18][CH2:17][N:16]([C:19]([CH:21]6[CH2:23][CH2:22]6)=[O:20])[CH2:15]5)=[N:11][NH:10][C:9]4=[O:24])=[C:4]([OH:25])[CH:3]=3)=[CH:42][C:38]=2[CH:39]=[CH:40]1Participants
Conditions
- Temperature
- 100 °C
Procedure
To a microwave vial were added 4-(4-bromo-2-hydroxyphenyl)-5-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one (45 mg, 0.110 mmol), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzofuran (45 mg, 0.184 mmol), cesium carbonate (130 mg, 0.399 mmol), and dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II)-dichloromethane adduct (6.0 mg, 0.00735 mmol), and the mixture was purged with nitrogen. 1,4-Dioxane (1 mL) and water (0.5 mL) were added to the mixture which was heated overnight at 100° C. Analysis by LCMS indicated desired product formation and consumption of starting material. The mixture was filtered through a syringe filter and purified by reverse phase HPLC (10-90% acetonitrile/water+0.1% TFA). The desired fractions were collected and added to a separatory funnel containing ethyl acetate. The aqueous phase was adjusted to pH˜6 with 1N aq HCl. The aqueous phase was extracted with ethyl acetate (3×), and the combined organics were washed with brine, dried over Na2SO4, and concentrated in vacuo to afford the title product as a white solid (18 mg, 37%). MS(ES)+ m/e 445.3 M+H]+.
Workup
- customthe mixture was purged with nitrogen
- addition1,4-Dioxane (1 mL) and water (0.5 mL) were added to the mixture which
- customdesired product formation and consumption of starting material
- filtrationThe mixture was filtered through a syringe
- filtrationfilter
- custompurified by reverse phase HPLC (10-90% acetonitrile/water+0.1% TFA)
- customThe desired fractions were collected
- additionadded to a separatory funnel
- additioncontaining ethyl acetate
- extractionThe aqueous phase was extracted with ethyl acetate (3×)
- washthe combined organics were washed with brine
- dry with materialdried over Na2SO4
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-4225849e79124265b7f89d9d1398bf9b
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09340529B2
Reaction notes
Loading…